共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
Lichen myxoedematosus is an unusual disorder of unknown etiology and pathogenesis. Although several treatments have reportedly been tried, therapeutic efficacies are variable and unsatisfactory. A patient with severe skin changes of this disease was successfully treated with PUVA photochemotherapy. PUVA therapy was carried out using 30 mg of 8-methoxypsoralen orally, and subsequent exposure to UVA starting at 4 J/cm2. The eruption disappeared almost completely after 35 treatments at a cumulative dose of 202 J/cm2. Histologically, mucin deposition was greatly diminished after the therapy. The photochemotherapy may exert its effect directly by inhibiting proliferation of fibroblasts and synthesis of mucopolysaccharides, and also indirectly by immunomodulating action. 相似文献
3.
Pimonpun Gritiyarangsan Apiradee Sukhum Poohglin Tresukosol Preya Kullavanijaya 《The Journal of dermatology》1998,25(5):299-301
Seventeen patients with persistent chronic hand eczema were treated with topical 0.1% 8-methoxypsoralen and UVA (PUVA) for 8 weeks. Significant improvement was achieved in 5 cases (29%), moderate improvement in 9 (53%), and little improvement in 3 (18%). The mean number of PUVA treatments was 22.2, and the mean total UVA dose was 63.5 J/cm2. There was no association between clinical response and duration of hand eczema, positive patch test reaction, or atopic status. Since topical PUVA has no risk of systemic side effects, it should be considered as an alternative treatment for patients with chronic hand eczema who are resistant to other topical medications. 相似文献
4.
目的:探索用改良PUVA疗法治疗慢性斑块性银屑病的疗效和安全性。方法:67例寻常型银屑病患者口服8-MOP0.6mg/kg后照射UVA和UVB,每周3次,共治疗8周,用PASI积分评价疗效,并记录不良反应。结果:治疗开始2-4周后出现疗效,随着治疗时间的延长,PASI总积分逐渐下降,有效率逐渐提高,在治疗结束时痊愈率达到96.5%,有效率达100%。27例患者(40.3%)出现不良反应,绝大多数为轻度,没有因不良反应停止治疗的病例。结论:改良PUVA疗法治疗慢性斑块性银屑病具有良好疗效和安全性。 相似文献
5.
Summary In a group of 40 patients suffering from wide-spread psoriasis oral administration of a retinoid (Ro 10-9359) was followed by PUVA therapy. The clearance rate was increased by 30% as compared to PUVA alone. Except for cheilitis no side effects were seen. Histological analysis in 20 patients before, during and after therapy revealed an intensification of psoriatic tissue changes after retinoid treatment. Loss of corneal layers, massive exoserosis, and neutrophil migration were prominent features. Mitotic counts were not increased by the pretreatment. The increased susceptibility of diseased skin to PUVA as produced by this drug appears to be based on several factors related to the tissue changes revealed by histology.Presented at the Niels-Stenson-Symposion, Appenrade, Denmark, October 28, 1978 相似文献
6.
Keiko Yamaguchi Izuho Takeuchi Noriko Yoshii Akira Gushi Takuro Kanekura Tamotsu Kanzaki 《The Journal of dermatology》1998,25(8):544-546
Topical PUVA therapy was applied to a patient with localized scleroderma. Her localized scleroderma responded very well to the topical PUVA therapy, i.e., her sclerotic skin softened to normal skin texture. However, despite this dramatic clinical change the histopathological findings did not change at all and were still “hard”. 相似文献
7.
P. Gritiyarangsan J. Sindhavananda P. Rungrairatanaroj P. Kullavanijaya 《Photodermatology, photoimmunology & photomedicine》1995,11(4):174-177
A total of 113 Thai patients who were treated with oral PUVA from 1979 to 1992 were examined for long-term cutaneous side effects of PUVA. Two psoriatic patients developed PUVA keratosis on non-sun-exposed areas. Both were skin type IV and had had phototherapy with UVB and sunlight previously. The total doses of UVA were 909 J/cm2 and 242 J/cm2 respectively. One psoriatic patient developed Bowen's disease. He had had a cumulative dose of UVA 2207 J/cm2. He also had a past history of arsenic intake and phototherapy with UVB and sunlight. PUVA lentigines were seen in 58 patients (51.4%). It was associated with older age at starting PUVA, higher cumulative UVA dose and greater number of PUVA treatment. This study suggests that previous exposure to other risk factors is important for inducing skin cancer in populations with skin phototype III, IV and V treated with oral PUVA. 相似文献
8.
J. H. Olafsson O. Larkö G. Roupe G. Granerus U. Bengtsson 《Archives of dermatological research》1986,278(3):228-231
Summary Chronic urticaria is a disease for which the available range of treatment modalities is limited. Ultraviolet radiation has recently been shown to affect histamine release from mast cells. We therefore studied the effects of PUVA and UVA on chronic urticaria. Nineteen patients took part in the study, which was designed as a randomized double-blind study. Eleven patients received PUVA, and 8 received UVA plus a placebo. In the PUVA group, 7 patients showed improvement, 3 noticed no change, and 1 became worse. In the group that received UVA plus placebo, 5 patients experienced an improvement, whereas the other 3 showed no change. The differences between the groups were not statistically significant. However, the probability of achieving this degree of improvement in both groups just by chance is less than 1%. Consequently, the improvement noted could have been due to either UVA alone or a placebo effect. It is concluded that PUVA is not better than UVA in the treatment of chronic urticaria. 相似文献
9.
Motonobu Nakamura Setsu Kobayashi Kunihiko Matsubara Toshihiro Tanaka Fukumi Furukawa Sadao Imamura 《The Journal of dermatology》1995,22(3):196-200
The effectiveness of non-interval topical PUVA treatment was studied in four patients with mycosis fungoides at the plaque stage. Five regions of each patient were exposed to UVA immediately, 30 minutes, 60 minutes, 90 minutes, and 120 minutes, after topical application of 8-methoxypsoralen, respectively. The effects of these treatments were evaluated by clinical appearance and histological findings after the 20th treatment. All five regions were more improved clinically and histologically than the control region, which was not given PUVA therapy. There were no clear differences clinically among these five regions. Biopsy specimens from each region revealed the disappearance of epidermotropism and a marked decrease in atypical mononuclear cell infiltrations in the dermis. From these data, we concluded that there were no clear differences between these five treatments clinically or histologically and that non-interval PUVA therapy is useful for the early stages of mycosis fungoides. To our knowledge, this is the first report of non-interval PUVA therapy for mycosis fungoides. 相似文献
10.
M. Kari Connolly 《Dermatologic therapy》2001,14(2):81-94
ABSTRACT: Scleroderma presents a formidable therapeutic challenge for both the physician and the patient. Over the years many medications and interventions have been reported to be beneficial in scleroderma. With equal regularity, however, when put to the test of the randomized controlled trial, many of these same medications have subsequently been shown to be ineffective. This is true for both the localized and systemic forms of the disease. Two of the most recent additions to this inauspicious list for systemic sclerosis include D-penicillamine and methotrexate. At the very least these outcomes should point to our deficiencies in understanding the pathogenesis of this unusual disorder. It should raise the possibility that collagen and inflammatory or immune cells are not good therapeutic targets and new targets should be sought. Despite the scope of these problems and the lack of definitive therapy, there is a great deal an individual physician can do to help a patient living with scleroderma. This article presents management approaches to patients with either localized or systemic scleroderma. 相似文献
11.
在实验动物中研究了即时型光化学疗法对表皮郎格单细胞数量和形态的影响及对接触过敏反应的抑制,并与常规使用的光化学疗法进行了对比,结果表明二种方法间无差异,3J/cm2的即时型光化学疗法无红斑反应并能引起郎格罕细胞数量和形态的变化,并且通过诱导抑制性淋巴细胞抑制接触过敏反应。还探讨了有关致癌的可能性。 相似文献
12.
13.
Zhun Rui Mok Eugene Sern‐Ting Tan Wei‐Sheng Chong 《The Australasian journal of dermatology》2017,58(1):e1-e4
Cutaneous plasmacytosis (CP) is an uncommon chronic disease of unknown aetiology, reported mainly in middle‐aged patients of Asian descent. It is diagnosed by a constellation of physical, laboratory, radiological and histopathological findings. We report a patient with CP who demonstrated a favorable and promising response to mask‐bath PUVA. 相似文献
14.
PUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of cataract is exceedingly rare. This paper discusses cataract formation, reviews the literature concerning the ocular complications of PUVA therapy and proposes guidelines for ocular protection during photochemotherapy. 相似文献
15.
Malignant melanoma in patients treated for psoriasis with PUVA 总被引:2,自引:0,他引:2
R. S. Stern 《Photodermatology, photoimmunology & photomedicine》1999,15(1):37-38
16.
We describe a case of systemic scleroderma associated with Graves' disease and review six previously described cases associating the two diseases. Our case seems to be unique in that Graves' disease preceded the occurrence of systemic scleroderma. 相似文献
17.
目的探讨系统性硬皮病(SSc)肢端型与弥漫型的临床特点及差异。方法回顾性分析47例肢端型和26例弥漫型SSc患者的临床资料,并比较两型差异。结果肢端型∶弥漫型≈1.81∶1;指趾骨吸收/溃疡、关节畸形/固定、趾雷诺现象、ACA(+)等发生率肢端型高于弥漫型(P<0.05~0.01);关节炎、肌炎、间质性肺炎、二/三尖瓣返流、肾脏受损等弥漫型高于肢端型(P<0.05~0.01);2例分别死于心衰和尿毒症,均属弥漫型。结论两型除皮肤变硬部位不同外,肢端型SSc以指、趾骨吸收、溃疡、关节畸形、固定功能障碍为显著临床特点;弥漫型SSc则以关节炎、肌炎、肺、心脏受累为显著临床特点。心肾受损可能是SSc致死的主要因素。 相似文献
18.
Hiroyuki Sakai Masaki Ibe Hidetoshi Takahashi Shinobu Matsuo Kensaku Okamoto Isao Makino Yukio Oomori Hajime Iizuka 《The Journal of dermatology》1996,23(1):42-46
Langerhans cell histiocytosis is currently regarded as a reactive proliferative process of Langerhans cells rather than a malignancy. The disease is characterized by Langerhans cell infiltration of skin, lung, bone and other organs. We report a 74-year-old man with Langerhans cell histiocytosis who had generalized hemorrhagic and crusted papules. He also had diabetes insipidus. Because he did not have any severe constitutional symptoms or failure of vital organs, we applied topical PUVA treatment to his skin lesions, which responded well to the therapy. Diabetes insipidus, however, remained, in spite of X ray radiotherapy for the pituiary lesion. 相似文献
19.
20.
Sixty-two and 38 psoriatic patients were treated with topical PUVA and combined etretinate and topical PUVA (Re-PUVA), respectively. In both groups, 50% of the patients showed initial recovery after 6 weeks and over 90% after 14 weeks. Re-PUVA was more effective than PUVA alone in obtaining complete clearance (p<0.05). To clear psoriasis in 50% of the patients, PUVA and Re-PUVA required 63 and 26 weeks, respectively. Furthermore, the integrated clearance rates after 70 weeks were 50% in PUVA and 63% in Re-PUVA. Each therapy showed a similar remission period; psoriasis recurred in 50% of the patients after 4 months. In addition, 17 patients were treated with oral etretinate, and Re-PUVA was found to be more effective than etretinate monotherapy. Another aim was to determine whether etretinate would inhibit the development of PUVA side effects. Adding etretinate failed to inhibit the production of PUVA lentigines but clearly suppressed antinuclear antibody (ANA) expression. Six of 56 patients treated with PUVA alone developed ANA during the treatment. In marked contrast (p=0.05), ANA was detected in none of 34 patients treated with Re-PUVA. 相似文献